Guillain-Barré syndrome (GBS) is a rare autoimmune disorder affecting about 1 in 100,000 people, according to the U.S. Centers for Disease Control and Prevention. While GBS is more common in men and ...

Please provide your email address to receive an email when new articles are posted on . Results from a phase 2 clinical trial showed that treatment with an IgG-cleaving enzyme for individuals ...

Experts say there has been an increase in a rare syndrome called Guillain Barré in Peru. The condition can occur when the immune system attacks the nervous system after either a viral or bacterial ...

The Task Force of the European Academy of Neurology and the Peripheral Nerve Society published updated guidelines in 2024 on the diagnosis and treatment of Guillain-Barré syndrome (GBS), which ...

Amid the near-total Israeli blockade, those in Gaza are facing a new threat to their lives — paralytic diseases. According to Nasser Hospital’s head of pediatrics, Dr. Ahmed Al-Farra, “Before the war, ...